This new platform bridges the gap between routine patient care and clinical research, creating a single, comprehensive wound ...

From AI-driven orchestration platforms to advanced data integration and oncology-specific analytics, clinical research tools are rapidly evolving to make trials faster, more accurate, and more patient ...

Key market opportunities lie in adopting leading metrics and KPIs for predictive project management in clinical research. By utilizing tools like Earned Value Management (EVM), organizations can ...

Worldwide becomes first CRO to implement Medidata Plus, gaining access to enterprise-level AI across the Medidata Study, Data, and Patient ExperiencesResearch Triangle Park, NC and New York – April 23 ...

By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...

"It's a remarkable time in specialized home healthcare and clinical research. For decades PCM and EmVenio have been on the frontline ensuring our services expand access and meet the needs of patients, ...

New platform upgrades streamline sponsor-site payments, automate invoice processing, and strengthen compliance across the clinical trial financial workflow RALEIGH, N.C., April 14, 2026 /PRNewswire/ - ...

Advances in AI, automation, wearable technology, and gene therapies are converging to transform clinical research practices. Developments range from Ocugen’s concentrated retinal gene therapy trial ...

Boulevard ( provider of the business management platform trusted by the fastest-growing salons, spas, and medspas, today announced the launch of ePrescribe, a new feature that brings secure electronic ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced it has entered into ...

The early recognition of type 1 diabetes in a toddler with increased thirst, lethargy, vision difficulties, and fruity breath ...

Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong ...